Mia's Feed
Medical News & Research

Most US Children Enroll in Medicaid But Coverage Gaps Persist by Age 18

Most US Children Enroll in Medicaid But Coverage Gaps Persist by Age 18

Share this article

A comprehensive study shows that while most children in the US enroll in Medicaid or CHIP by age 18, many face coverage gaps, risking long-term access to essential health services amid recent policy changes.

2 min read

A recent study highlights that by the time children reach 18 years old in the United States, a significant majority have been enrolled in Medicaid or the Children's Health Insurance Program (CHIP), yet many experience interruptions in their coverage during childhood. According to a microsimulation model developed by researchers at Harvard T.H. Chan School of Public Health, about 61% of children will have enrolled in these programs by age 18, but 42% will have faced periods of being uninsured at some point.

This comprehensive study is the first to track the cumulative insurance experience of children over their entire childhood, providing vital insights into the reach and limitations of Medicaid and CHIP, especially amidst recent policy changes. The study was published in the Journal of the American Medical Association (JAMA).

The research contextualizes recent policy shifts, such as the termination of approval for multiyear continuous coverage waivers by the Centers for Medicare and Medicaid Services in July 2025. Additionally, the federal budget reconciliation law passed the same month projects a reduction of Medicaid funding by $1 trillion, with an anticipated loss of 10 to 15 million enrollees. These factors could further impact long-term insurance coverage among children.

To mitigate data limitations, the researchers used a combination of national natality, socioeconomic, demographic, and insurance data to simulate individual insurance trajectories from birth through age 18. Their findings estimate that, under current policies similar to those from 2015 to 2019, 61% of children will have enrolled in Medicaid/CHIP, but a notable 42% will have experienced coverage gaps.

The study also reveals disparities based on state Medicaid expansion status. Children born in non-expansion states are more likely to face gaps, with 59% experiencing uninsured periods compared to 36% in expansion states. States with more restrictive income eligibility thresholds for Medicaid and CHIP see higher rates of coverage interruption.

Senior author Nicolas Menzies emphasizes concern over future policy changes potentially exacerbating these gaps, especially affecting noncitizen children and families facing work requirements or state-level Medicaid cuts. Overall, the findings underscore the importance of safeguarding and improving long-term coverage for vulnerable pediatric populations.

Source: [https://medicalxpress.com/news/2025-09-majority-children-enroll-medicaid-coverage.html]

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Reducing Energy Waste in CT Scanners: A Sustainable Step Forward

Innovative research shows that turning off surplus CT scanners during off-hours can significantly reduce energy consumption in hospitals, contributing to more sustainable healthcare.

Hunger and Neural Circuits Delay Puberty Onset in Mice

Neuroscientists at RIKEN have identified neural pathways linking hunger to delayed puberty in female mice, unveiling potential mechanisms shared with humans that connect nutrition and reproductive development.

Research Links Beta-HPV to Skin Cancer in Immunocompromised Individuals

New research reveals that Beta-HPV can directly cause skin cancer in immunocompromised individuals, emphasizing the role of immune health in cancer prevention.

Innovative Breast Cancer Treatment Merges Light Therapy and Iron-Induced Cell Death

A novel dual-action breast cancer therapy combines light-activated drugs with iron-based cell destruction, offering a targeted and safer treatment option with fewer side effects.